ResearcherUniversity of California San DiegoNo recent work listed
Michael A. Turner
Matched on ORCID iD 0000-0001-8949-3136; OpenAlex author ID A5013221670. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2022: 2 papers · 2023: 2 papers
Papers 4
- Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse … First author DOI 10.1245/s10434-022-12466-4↗
- Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study. Co-author DOI 10.3390/jpm13050857↗
- Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft. Co-author DOI 10.21873/invivo.12676↗
- Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. First author DOI 10.3390/biom12050711↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael Bouvet · 4 shared papers, 2022–2023 · strength 0.67
- Paper Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreati… DOI 10.1245/s10434-022-12466-4↗
- Paper Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. DOI 10.3390/biom12050711↗
- Paper Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Mod… DOI 10.3390/jpm13050857↗
- Hiroto Nishino · 4 shared papers, 2022–2023 · strength 0.67
- Paper Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreati… DOI 10.1245/s10434-022-12466-4↗
- Paper Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. DOI 10.3390/biom12050711↗
- Paper Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Mod… DOI 10.3390/jpm13050857↗
- Robert M. Hoffman · 4 shared papers, 2022–2023 · strength 0.67
- Paper Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreati… DOI 10.1245/s10434-022-12466-4↗
- Paper Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. DOI 10.3390/biom12050711↗
- Paper Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Mod… DOI 10.3390/jpm13050857↗
- Thinzar Min Lwin · 3 shared papers, 2022–2023 · strength 0.51
- Paper Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreati… DOI 10.1245/s10434-022-12466-4↗
- Paper Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. DOI 10.3390/biom12050711↗
- Paper Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft. DOI 10.21873/invivo.12676↗
- Surinder K. Batra · 2 shared papers, 2022–2023 · strength 0.30
- Kavita B. Mallya · 2 shared papers, 2022–2023 · strength 0.30
- Kristin E. Cox · 1 shared paper, 2023 · strength 0.16
- Aaron M. Mohs · 1 shared paper, 2023 · strength 0.16
- Andrew M. Lowy · 1 shared paper, 2022 · strength 0.14
- Sukhwinder Kaur · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.